1. Introduction {#sec1}
===============

More than 230 million major surgical procedures are undertaken each year worldwide \[[@B1]\] and postoperative complications imposed a significant clinical and economic burden to surgical patients as well as the public health systems \[[@B2], [@B3]\]. Postoperative pulmonary complications (PPCs) are common postoperative complications that occur in 2% to 40% of patients and are associated with increased morbidity, mortality, and length of stay (LOS) \[[@B3]--[@B9]\]. In noncardiac patients, PPCs occur more frequently than cardiac complications \[[@B10]\]. Though it came to wide attention in recent years, the literature investigating the incidence and outcome of PPCs in Chinese inpatients remains scarce.

It is known that PPCs have a multifactorial etiology and had been defined broadly, including respiratory tract infection, pneumonia, respiratory failure, atelectasis, pleural effusion, pneumothorax, bronchospasm, and aspiration pneumonitis \[[@B11]\]. Previous studies demonstrated that PPCs were associated with a series of perioperative risk factors, such as age, smoking, chronic obstructive pulmonary disease (COPD), type of surgery, and serum albumin \[[@B4], [@B6], [@B7], [@B11]--[@B14]\]. A majority of these risk factors can be intervened and improved \[[@B15]--[@B17]\]. Therefore, identifying perioperative risk factors of PPCs is an important step toward improving quality of care in surgical patients, which has been already explored in several studies \[[@B11], [@B12], [@B18]\].

In the United States, Arozullah et al. developed a multifactorial risk index to predict the postoperative pneumonia after major noncardiac surgery \[[@B12]\]. In Canada, McAlister et al. paid attention to the nonthoracic surgery \[[@B7]\]. They found the incidence of PPCs is 8% and identified the preoperative risk factors. Dupont et al. also investigated five independent predictive factors of postoperative pneumonia in France \[[@B19]\]. A recently published risk-prediction equation for PPCs was a significant advance in this field, which identified seven independent risk factors for PPCs by Canet et al. \[[@B11]\]. The researchers further tested this predictive risk score in a large European cohort and found this risk score performed differently between geographic areas \[[@B20]\]. In China, the most populous developing country in the world, however, very limited information about PPCs has been reported so far. Since China is different from the USA and European countries in geographic areas, race, disease spectrum, and social psychological background, investigations assessing the incidence and characteristics of PPCs in Chinese surgical cohorts are indispensable. Hence we conducted the present study to assess the incidence and risk factors of PPCs after noncardiac surgery in China and to develop a risk index of PPCs which is applicable for Chinese inpatients. The results of the present study would help health care providers to understand the existing situation of PPCs in China, to identify high-risk patients from the generic surgical population, and to guide individualized perioperative respiratory care.

2. Materials and Methods {#sec2}
========================

2.1. Study Settings and Patients {#sec2.1}
--------------------------------

We conducted a prospective, multicenter, and observational study of inpatients undergoing noncardiac surgical procedures. This study was performed at 4 university hospitals located in Zhejiang province, China (the First Affiliated Hospital, Zhejiang University School of Medicine, the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, the First Affiliated Hospital, Wenzhou Medical College, and the Second Affiliated Hospital, Wenzhou Medical College). The inpatients undergoing surgical procedures between August 6, 2012, and August 12, 2012 were enrolled into the study. All patients would receive routine care, and no research-related intervention would be introduced.

2.2. Inclusion and Exclusion Criteria {#sec2.2}
-------------------------------------

All noncardiac operations performed under general, spinal, epidural, or regional anesthesia were eligible for inclusion. The exclusion criteria were as follows: (1) younger than 18 years; (2) pregnancy; (3) organ transplantation; (4) procedures performed under local nerve anesthesia; (5) procedures outside the operating room; (6) outpatient procedures (who had an LOS in hospital less than 24 hours); (7) reoperation related to a previous surgical complication; (8) patients with preoperatively intubated trachea.

2.3. Data Collection {#sec2.3}
--------------------

Two trained anesthesiologists were assigned at each center to collect the following data: (1) generic information: date of surgery and hospital admission/discharge, age, gender, American society of anesthesiologists (ASA) physical status, height and weight, smoking status, alcohol use, and chronic comorbid disease; (2) preoperative variables: respiratory infection in the last month, antibiotic use, nasogastric tube, saturation of peripheral oxygen (SpO~2~), and laboratory results (leucocytes count, neutrophil, hemoglobin, serum creatinine, serum albumin, and fasting blood glucose); (3) intraoperative variables: anaesthetic technique, surgery (type, site, and duration), nasogastric tube, bladder catheter, central venous catheter, blood loss, blood transfusion, pulmonary, and cardiovascular complications; (4) postoperative variables: clinic (SpO~2~, mechanical ventilation, vasoactive drugs) and laboratory results within 2 hours after surgery. After operation, surgeon and nurses visited the patients every day and recorded incidence of PPCs. The PPCs were defined in [Table 1](#tab1){ref-type="table"} \[[@B11]\]. Postoperative mortality was defined as death within 60 days of surgery.

2.4. Outcomes {#sec2.4}
-------------

The primary outcome was the occurrence of PPCs, the postoperative LOS, and the postoperative mortality rate. The secondary outcome is the predictive risk index of PPCs.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Quantitative data were presented as means and standard deviations (SD) or median and interquartile range (IQR; from 25th to 75th percentiles) as appropriate. Qualitative data were reported as *N* (%). Student\'s *t*-test or Mann-Whitney *U* test were used for comparison of continuous variables and the chi-squared test or Fisher\'s exact test for categorical variables to test the relationship between each potential risk factors and PPCs.

In order to develop a risk index of PPCs, enrolled patients were further divided into two cohorts. Cohort 1 composed of patients from two hospitals and was used to develop the predictive index, while cohort 2 was used to validate the index. In cohort 1, risk factors were firstly analyzed using univariate analysis (*P* \< 0.05). Then a multivariate logistic regression was conducted in cohort 1 with the occurrence of PPCs as the dependent factor, incorporating all risk factors on the basis of correlation coefficients between variables lower than 0.4. The forward LR mode was adopted in the process of regression. The adjusted odds ratios (OR) and the confidence intervals (CI) were also calculated. A brief predictive index was then calculated by multiplying the regression (*β*) by 10 and rounding off to the nearest integer \[[@B12]\]. The brief predictive index then validated in cohort 2 to evaluate the model\'s discriminatory capability, and the area under the receiver operating characteristic (ROC) curve was displayed (*c*-statistic).

Data were analyzed using SPSS 16.0 (SPSS inc., Chicago, USA). All these tests were two-tailed and statistical significance was considered when a *P* value was less than 0.05.

3. Results {#sec3}
==========

3.1. Demographic and Clinical Characteristics {#sec3.1}
---------------------------------------------

Between August 6, 2012, and August 12, 2012, 2001 patients were undergoing noncardiac surgery, of which 328 were excluded according to the inclusion criteria or lost. Consequently, the final sample included in the statistical analysis consisted of 1673 patients, 902 in cohort 1 and 771 in cohort 2 ([Figure 1](#fig1){ref-type="fig"}). The basic characteristics of the study subjects are detailed in [Table 2](#tab2){ref-type="table"}.

3.2. PPCs, LOS, and Mortality {#sec3.2}
-----------------------------

A total of 163 (9.7% of the 1673 patients) patients were recorded with 237 episodes of PPCs. Postoperative respiratory failure developed in 30 patients (1.8%), bronchospasm in 48 (2.9%), pleural effusion in 7 (0.4%), respiratory infection in 131 (7.8%), atelectasis in 19 (1.1%), cardiopulmonary edema 1 (0.06%), and pneumothorax in 1 (0.06%). Most PPCs occurred after upper gastrointestinal surgery (40.4%), followed by thoracic (38.8%), neurosurgery (22.2%), kidney (14.3%), hepatobiliary (13.5%), and lower gastrointestinal surgeries (11.8%). The median postoperative LOS was longer in patients with PPCs (16 days, IQR 10--23 days) than in those without PPCs (8 days, IQR 5--13 days) (*P* \< 0.001), especially in orthopaedics (*P* = 0.03), breast (*P* \< 0.001), gynaecology (*P* \< 0.001), lower gastrointestinal (*P* \< 0.001), and hepatobiliary (*P* \< 0.001) surgery. The detailed information on the characteristics of PPCs and LOS was shown in [Table 3](#tab3){ref-type="table"}.

Four (0.24%) patients died in the hospital, 3 (1.84%) of the 163 patients with PPCs and 1 (0.07%) of the 1510 patients without PPCs; the mortality was significantly higher in patients with PPCs than those without (*P* \< 0.001).

3.3. Risk Factors and PPCs {#sec3.3}
--------------------------

The variables having a statistically significant impact on the incidence of PPCs detected from the cohort 1 are shown in [Table 4](#tab4){ref-type="table"}. Then the independent variables were entered into the logistic regression model, except for these have high collinearity with others (intraoperative blood loss and duration of surgery; intraoperative blood loss and central venous catheter; intraoperative blood loss and blood transfusion; postoperative ventilation and vasoactive drug; pre- and intraoperative nasogastric tube; pre- and postoperative hemoglobin). Multivariable logistic regression indicated that 9 of those potential predictors were present in the final model. The raw and adjusted odds ratios for the nine variables are shown in [Table 5](#tab5){ref-type="table"}, which also shows the brief predictive index derived from the *β* coefficient for each variable. This nine-variable regression model had good discrimination and calibration values in cohort 1 (*c*-statistic 0.91, 95% CI, and from 0.89 to 0.94). The ROC curves and the *c*-statistics for the validation subsamples (cohort 2) are shown in [Figure 2](#fig2){ref-type="fig"}. The brief predictive index developed in the present study has potential advantage in predicting PPCs in Chinese inpatients (better *c*-statistic than the risk index in the study of Canet et al.) \[[@B11]\]. The most relevant cut point was the score of 13 (sensitivity 90.2%, specificity 79.4%). [Table 6](#tab6){ref-type="table"} shows the incidence of PPCs by risk index score, the number of patients in each risk class, and the actual incidence of PPCs in cohort 1 and cohort 2.

3.4. Strategies to Reduce PPCs {#sec3.4}
------------------------------

Opportunities to reduce risk for PPCs occur throughout the perioperative period. [Table 7](#tab7){ref-type="table"} summarizes perioperative interventions that have been recommended to decrease the risk of PPCs \[[@B15], [@B16], [@B21], [@B22]\].

4. Discussion {#sec4}
=============

This prospective study assessed the 9.7% incidence of PPCs after noncardiac surgery in Chinese university hospitals and found increased hospital LOS by 8 days in patients with PPCs than those without. Furthermore, we identified the perioperative risk factors of PPCs and developed a brief risk index for predicting PPCs in Chinese inpatients.

In the current study, the incidence of PPCs after noncardiac surgery and the hospital LOS in patients with PPCs were comparable to the incidence observed in some previous studies \[[@B11], [@B23]--[@B25]\]. The high incidence of PPCs and the increased hospital LOS indicating PPCs is also an important public health issue demanding nationwide attention in China. Unexpectedly, we found the postoperative mortality in patients with PPCs was lower than several previous results \[[@B3], [@B11]\]. This may be in association with the higher percentage of ASA class 1 to 2 patients and younger median age. Firstly, the medical resources in China were mainly concentrated in larger hospitals, especially the university hospitals and tertiary hospitals. So the patients always chose to go to large hospitals directly, even if they only have a cold or want to remove a small lipoma on body surface. Secondly, the percentage of emergency surgery in the present study was low, since none of the four studied hospitals had a major trauma center.

Nine independent risk factors were finally selected to participate in the brief predictive index for PPCs, including smoking, respiratory infection in the last month, antibiotic use, SpO~2~, surgery site and blood lost, blood glucose, albumin, and ventilation.

Among the preoperative risk factors, smoking, a history of respiratory infection in the last month, SpO~2~, and antibiotic use are strong PPC risk factors. Smoking and respiratory infection may lead to local changes in airway reactivity, pulmonary function, and residual impairment of immunity, which could increase the risk of PPCs for several folds \[[@B6], [@B7]\]. SpO~2~ is an easily recorded objective measure, which reflects the respiratory function as well as cardiovascular functional status \[[@B11]\]. Antibiotic use is a protective factor in the current cohort. It seems to be helpful to use prophylactic antibiotic, especially in these high-risk patients.

The intraoperative risk factors were identified in the present study including surgery site and blood loss, which were similar to many previous studies \[[@B4], [@B7], [@B14], [@B26]\]. Thoracic and abdominal surgeries are always performed via a large painful incision associated with obviously changes in lung compliance and functional residual capacity. As a result, the incidence of PPCs in these surgeries is much higher than others. Significant intraoperative blood loss gives rise to haemodynamic instability and relative ischaemia and so causes ischaemia-reperfusion injury, which can lead to organ dysfunction.

Factors in early stage of postoperative may have a better performance in predicting PPCs. We found postoperative mechanical ventilation, albumin, and blood glucose could increase the risk of PPCs. Among them, ventilation is the most important risk factor for PPCs. Researchers found an increased risk of respiratory events in patients with ventilation \[[@B26], [@B27]\]. It is important to follow the guidelines for the management of ventilation and the prevention of nosocomial infection.

A brief risk score based on these factors was calculated to predict the incidence of PPCs. In Spain, Canet and coworkers also developed a similar risk index of PPCs \[[@B11]\]. Three of these risk factors (preoperative SpO~2~, respiratory infection in the last month, and surgery site) were also identified in the current study. What is more, the brief predictive index developed in the present study has potential advantage in predicting PPCs in Chinese inpatients (better *c*-statistic than the risk index of Canet). This disparity may be due to the different geographic areas, ethnic, cultural, socioeconomic, and political differences between China and Spain. In fact, the risk index developed by Canet also performed differently between the Western Europe sample and the Eastern Europe sample \[[@B20]\]. In general, the current brief predictive index predicted the risk of PPCs well in both the development and validation cohorts. These findings suggest patients with high risk of PPCs should be closely monitored and early intervened if the risks factors could be modified.

Several limitations in our study should be acknowledged. First of all, only four university hospitals participated. This may result in some bias. Further studies targeting general Chinese hospitals with a larger population are still needed. Another limitation is that the 7-day study period was arbitrarily decided. All patients were enrolled in August. Englesbe et al. demonstrated a significant seasonal variation in surgical morbidity and mortality \[[@B28]\]. They found a dramatic worsening of surgical mortality in July, which was attributed to the influx of inexperienced trainees. However, Ehlert and colleagues refuted the "July Phenomenon" in a larger population \[[@B29]\]. In most hospitals in China, July is marked by an influx of intern. Instead of managing patients directly, they only do the paperwork. Therefore, they may have little effect on the present results. Further study is needed to confirm the impact of seasonal variation in surgical morbidity and mortality.

5. Conclusion {#sec5}
=============

The present prospective, multicenter study found there was high incidence of PPCs which increased hospital LOS in noncardiac surgical inpatients in China. We identified nine objective and easily assessed factors associated with the occurrence of PPCs. A simple risk index based on these factors predicted the development of PPCs. This brief predictive index may be useful for clinicians in estimating patients\' risk for PPCs and guide individualized perioperative respiratory care.
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###### 

Definitions of postoperative pulmonary complications.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---
  *Respiratory infection*                                                                                                                                                                                                    
  Treatment with antibiotics for a respiratory infection, plus at least one of the following criteria: new or changed sputum, new or changed lung opacities, fever, and leukocyte count \>12,000/mm^3^                       
                                                                                                                                                                                                                            
  *Respiratory failure*                                                                                                                                                                                                      
  Postoperative PaO~2~ \<60 mmHg on room air, a ratio of PaO~2~ to inspired oxygen fraction \<300, or SaO~2~ \<90% and requiring oxygen therapy                                                                              
                                                                                                                                                                                                                            
  *Pleural effusion*                                                                                                                                                                                                         
  Chest radiograph demonstrating blunting of the costophrenic angle, evidence of displacement of adjacent anatomical structures, or (in supine position) a hazy opacity in one hemithorax with preserved vascular shadows    
                                                                                                                                                                                                                            
  *Atelectasis*                                                                                                                                                                                                              
  Collapse of the alveoli, lung opacification with shift of the mediastinum, hilum, or hemidiaphragm toward the affected area, and compensatory overinflation in the adjacent nonatelectatic lung                            
                                                                                                                                                                                                                            
  *Pneumothorax*                                                                                                                                                                                                             
  A collection of air in the pleural space (the area with no vascular bed surrounding the visceral pleura)                                                                                                                   
                                                                                                                                                                                                                            
  *Bronchospasm*                                                                                                                                                                                                             
  Newly detected expiratory wheezing treated with bronchodilators                                                                                                                                                            
                                                                                                                                                                                                                            
  *Aspiration pneumonitis*                                                                                                                                                                                                   
  Acute lung injury after the inhalation of regurgitated gastric contents                                                                                                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---

PaO~2~: partial pressure of oxygen in arterial blood; SaO~2~: arterial oxyhemoglobin saturation.

###### 

Demographic and clinical characteristics.

                                                     Overall             Cohort 1             Cohort 2            *P* ^\*^
  -------------------------------------------------- ------------------- -------------------- ------------------- ----------
  Male, *n* (%)                                      770 (46.0)          436 (48.3)           334 (43.3)          0.04
  Age, yr                                            49 (37--60)         48 (36--60)          49 (39--60)         0.69
  Education, yr                                      9 (6--9)            9 (6--9)             9 (9--14.5)         0.31
  Smoking status, *n* (%)                                                                                         0.85
   Never smoker                                      1397 (83.5)         753 (83.5)           644 (83.5)           
   Former smoker                                     222 (13.3)          118 (13.1)           104 (13.5)           
   Current smoker                                    54 (3.2)            31 (3.4)             23 (3.0)             
  Drinker, *n* (%)                                                                                                0.47
   Never drinker                                     1487 (88.9)         804 (89.1)           683 (88.6)           
   Former drinker                                    152 (9.1)           83 (9.2)             69 (8.9)             
   Current drinker                                   34 (2.0)            15 (1.7)             19 (2.5)             
  Body mass index, kg/m^2^                           22.3 (20.3--24.3)   22.1 (20.3--24. 2)   22.4 (20.3--24.3)   0.85
  Preoperative SpO~2~, %                             98 (98-99)          98 (98-99)           98 (98-98)          0.45
  Respiratory infection in the last month, *n* (%)   28 (1.7)            16 (1.8)             12 (1.6)            0.85
  ASA physical status, *n* (%)                                                                                    0.43
   1                                                 830 (49.6)          464 (51.4)           366 (47.5)           
   2                                                 722 (43.2)          380 (42.1)           342 (44.4)           
   3                                                 114 (6.8)           54 (6.0)             60 (7.8)             
   4                                                 5 (0.3)             3 (0.3)              2 (0.3)              
   5                                                 2 (0.1)             1 (0.1)              1 (0.1)              
  Emergency surgery, *n* (%)                         102 (6.1)           55 (6.1)             47 (6.1)            0.99
  Anesthesia, *n* (%)                                                                                             0.24
   General and combined^\#^                          1251 (74.8)         664 (73.6)           587 (76.1)           
   Neuraxial/regional                                422 (25.2)          238 (26.4)           184 (23.9)           
  Surgical site, *n* (%)                                                                                          \<0.001
   Peripheral                                        1015 (60.7)         620 (68.7)           395 (51.2)           
   Abdominal                                         600 (35.9)          243 (26.9)           357 (46.3)           
   Intrathoracic                                     58 (3.5)            39 (4.3)             19 (2.5)             
  Duration of surgery, h                                                                                          0.63
   ≤2 h                                              1238 (74.0)         659 (73.1)           579 (75.1)           
   2-3 h                                             235 (14.0)          132 (14.6)           103 (13.4)           
   \>3 h                                             200 (12.0)          111 (12.3)           89 (11.5)            
  LOS, d                                             8 (5--14)           9 (6--14)            8 (5--13)           0.01

Data are median (quartile) unless otherwise specified.

SpO~2~: saturation of peripheral oxygen; ASA: American society of anesthesiologists; LOS: length of stay.

^\*^Cohort 1 versus cohort 2; ^\#^this category included general anesthesia alone and general anesthesia combined with regional blockade.

###### 

Incidence of PPCs with LOS according to surgical specialties.

                            All patients   PPCs, *n* (%)   LOS (day)     *P*           
  ------------------------- -------------- --------------- ------------- ------------- ---------
  Total                     1673           163 (9.7)       16 (10--23)   8 (5--13)     \<0.001
  Surgical specialty                                                                    
   Orthopaedics             303            10 (3.3)        22 (14--31)   11 (6--17)    0.03
   Breast                   72             2 (2.8)         20 (19--21)   4 (3--8)      \<0.001
   Gynaecology              208            16 (7.7)        10 (7--19)    6 (4--8)      \<0.001
   Vascular                 33             1 (3.0)         16 (16--16)   9 (7--13)     0.45
   Upper gastrointestinal   47             19 (40.4)       18 (16--21)   17 (13--20)   0.68
   Lower gastrointestinal   136            16 (11.8)       17 (15--28)   11 (6--15)    \<0.001
   Hepatobiliary            229            31 (13.5)       24 (16--33)   8 (5--14)     \<0.001
   Urology                  168            7 (4.2)         16 (13--38)   8 (6--11)     0.16
   Kidney                   56             8 (14.3)        13 (10--17)   10 (7--14)    0.65
   Head and neck            147            9 (6.1)         4 (3--7)      7 (5--9)      0.21
   Thoracic                 49             19 (38.8)       12 (10--15)   14 (9--16)    0.36
   Neurosurgery             36             8 (22.2)        22 (12--27)   18 (12--25)   0.40
   Endocrinology            147            14 (9.5)        8 (7--14)     7 (6--8)      0.11
   Others                   41             4 (2.4)         10 (7--26)    7 (5--9)      0.16

Data are median (quartile) unless otherwise specified.

PPCs: postoperative pulmonary complications; LOS: length of stay.

###### 

Distribution of results of independent variables in cohort 1.

                                                Number of patients   Number (%) of patients with PPCs   *P*
  --------------------------------------------- -------------------- ---------------------------------- ---------
  Age, yr                                                                                               \<0.001
   \<59                                         670                  65 (9.7)                            
   ≥60                                          232                  47 (20.3)                           
  ASA physical status                                                                                   \<0.001
   1                                            464                  20 (4.3)                            
   2                                            380                  77 (20.3)                           
   3                                            54                   13 (24.1)                           
   4                                            3                    1 (33.3)                            
   5                                            1                    1 (100.0)                           
  Smokers                                                                                               0.001
   No                                           753                  79 (10.5)                           
   Yes                                          149                  33 (22.1)                           
  Respiratory infection in the last month                                                               \<0.001
   No                                           886                  101 (11.4)                          
   Yes                                          16                   11 (68.8)                           
  Diabetes                                                                                              0.001
   No                                           846                  97 (11.5)                           
   Yes                                          56                   15 (26.8)                           
  COPD                                                                                                  \<0.001
   No                                           890                  106 (11.9)                          
   Yes                                          12                   6 (50.0)                            
  Cirrhosis                                                                                             0.014
   No                                           895                  109 (12.2)                          
   Yes                                          7                    3 (42.9)                            
  Stroke/transient ischaemic attack                                                                     0.001
   No                                           887                  106 (12.0)                          
   Yes                                          15                   6 (40.0)                            
  Preoperative antibiotic use                                                                           \<0.001
   No                                           298                  19 (6.4)                            
   Yes                                          604                  93 (15.4)                           
  Preoperative SpO~2~, %                                                                                \<0.001
   ≥96                                          845                  92 (10.9)                           
   \<96                                         57                   20 (35.1)                           
  Preoperative anemia                                                                                   0.007
   No                                           837                  97 (11.6)                           
   Yes                                          65                   15 (23.1)                           
  Preoperative LOS, d                                                                                   0.002
   \<2                                          126                  5 (4.0)                             
   ≥2                                           776                  107 (13.8)                          
  Surgery site                                                                                          \<0.001
   Peripheral                                   620                  36 (5.8)                            
   Abdominal                                    243                  56 (23.0)                           
   Intrathoracic                                39                   20 (51.3)                           
  Anesthesia                                                                                            \<0.001
   Regional                                     238                  10 (4.2)                            
   General                                      664                  102 (15.4)                          
  Intraoperative nasogastric tube                                                                       \<0.001
   No                                           847                  85 (10.0)                           
   Yes                                          55                   27 (49.1)                          
  Intraoperative bladder catheter                                                                       \<0.001
   No                                           466                  28 (6.0)                            
   Yes                                          436                  84 (19.3)                           
  Intraoperative central venous catheter                                                                \<0.001
   No                                           821                  85 (10.4)                           
   Yes                                          81                   27 (33.3)                           
  Intraoperative blood loss, mL                                                                         \<0.001
   \<100                                        636                  32 (5.0)                            
   ≥100                                         266                  80 (30.1)                           
  Intraoperative blood transfusion                                                                      \<0.001
   No                                           875                  102 (11.7)                          
   Yes                                          27                   10 (37.0)                           
  Duration of surgery, h                                                                                \<0.001
   ≤2 h                                         659                  47 (7.1)                            
   \>2 to 3 h                                   132                  27 (20.5)                           
   \>3 h                                        111                  38 (34.2)                           
  Postoperative SpO~2~, %                                                                               \<0.001
   ≥96                                          891                  101 (11.3)                          
   \<96                                         11                   11 (100.0)                          
  Postoperative leucocyte, 10^9^/L                                                                      \<0.001
   \<4                                          6                    2 (33.3)                            
   4--10                                        665                  47 (7.1)                            
   \>10                                         231                  63 (27.3)                           
  Postoperative anemia                                                                                  0.009
   No                                           793                  90 (11.3)                           
   Yes                                          109                  22 (20.2)                           
  Postoperative fasting blood glucose, mmol/L                                                           \<0.001
   ≤6.1                                         778                  50 (6.4)                            
   \>6.1                                        124                  62 (50.0)                           
  Postoperative creatinine, *μ*mol/L                                                                    \<0.001
   ≤115                                         872                  99 (11.4)                           
   \>115                                        30                   13 (43.3)                           
  Postoperative albumin, g/L                                                                            \<0.001
   \<35                                         244                  85 (34.8)                           
   ≥35                                          658                  27 (4.1)                            
  Postoperative ventilation                                                                             \<0.001
   No                                           878                  97 (11.0)                           
   Yes                                          24                   15 (62.5)                           
  Postoperative vasoactive drug                                                                         \<0.001
   No                                           893                  105 (11.8)                          
   Yes                                          9                    7 (77.8)                            

Smoking: defined as patients who smoked up to 1 year before surgery; Anemia: defined as hemoglobin \<100 g/L.

PPCs: postoperative pulmonary complications; ASA: American society of anesthesiologists; COPD: chronic obstructive pulmonary disease; SpO~2~: saturation of peripheral oxygen; LOS: length of stay.

###### 

Independent predictors of risk factors for PPCs.

  -------------------------------------------------------------------------------------------------------
                                                     OR (95% CI) \         *β* coefficient   Risk score
                                                     *n* = 902                               
  -------------------------------------------------- --------------------- ----------------- ------------
  Respiratory infection in the last month            7.03 (1.66--29.80)    1.950             20

  Smokers                                            2.37 (1.27--4.42)     0.861             9

  Preoperative antibiotic use                        0.238 (0.11--0.54)    −1.436            −14

  Preoperative SpO~2~ \<96%                          5.56 (2.38--12.98)    1.715             17

  Surgery site                                                                                

   Peripheral                                        1                                        

   Abdominal                                         2.88 (1.49--5.59)     1.058             11

   Intrathoracic                                     12.20 (4.61--32.28)   2.501             25

  Intraoperative blood loss ≥100 mL                  3.00 (1.64--5.50)     1.100             11

  Postoperative fasting blood glucose \>6.1 mmol/L   2.60 (1.91--3.54)     0.956             10

  Postoperative albumin \<35 g/L                     4.21 (2.24--7.92)     1.438             14

  Postoperative ventilation                          7.20 (1.96--26.45)    1.975             20
  -------------------------------------------------------------------------------------------------------

PPCs: postoperative pulmonary complications; SpO~2~: saturation of peripheral oxygen.

###### 

Distribution of PPCs risk index scores in patients.

                                      Risk class                            
  ----------------------------------- ------------ ------------ ----------- -----------
  Cohort 1, *n* (%)                   672 (74.5)   127 (14.1)   67 (7.4)    36 (4.0)
  Cohort 2, *n* (%)                   577 (74.8)   110 (14.3)   54 (7.0)    30 (3.9)
  Rate of PPCs in cohort 1, *n* (%)   21 (3.1)     22 (17.3)    38 (56.7)   31 (86.1)
  Rate of PPCs in cohort 2, *n* (%)   5 (0.9)      17 (15.5)    12 (22.2)   17 (56.7)

PPCs: postoperative pulmonary complications.

###### 

Interventions to reduce the risk of PPCs.

  ------------------------------------------------------------------------------------------------------------------------------- ---
  *Preoperative interventions*                                                                                                     

   A careful history taking and physical examination                                                                               

   Encourage cessation of smoking for at least 2 months                                                                            

   Appropriate use of antibiotics and delay surgery if respiratory infection is present                                            

   Recommend a regular exercise program (e.g., walking, upper limb exercises, swimming, pool exercises, etc.)                      

   Treat patients with established asthma with inhaled corticosteroids                                                             

   Treat patients with established COPD with regular bronchodilators                                                               

                                                                                                                                  

  *Intraoperative interventions*                                                                                                   

   Substitute less ambitious procedure for upper abdominal or thoracic surgery when possible                                       

   Minimize blood loss                                                                                                             

   Limit duration of surgery to less than 3 hr                                                                                     

   Whenever possible, use spinal or epidural anesthesia                                                                            

                                                                                                                                  

  *Postoperative interventions*                                                                                                    

   Recommend regular lung expansion modalities such as deep breathing exercises                                                    

   Perform selective decompression of abdominal contents using nasogastric tube if patient is experiencing symptomatic gastric\    
   distension                                                                                                                     

   As soon as possible after surgery, have the patient sit up in a chair                                                           
  ------------------------------------------------------------------------------------------------------------------------------- ---

PPCs: postoperative pulmonary complications; COPD: chronic obstructive pulmonary disease.
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